Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.
A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...
Akebia Therapeutics has scrapped plans for trial that would have potentially led to an expansion of the patient population for its new anemia drug Vafseo, the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback